In this study, the local promotion function of UTMD technology was combined with drug and gene-loaded nanoparticles, which significantly improved the delivery efficiency of gemcitabine and periostin silencing, as well as the therapeutic effect against pancreatic cancer. The gene discussed is POSTN; the disease is pancreatic neoplasm.